The New York Times

That is good news for patients, but officials fear it will make controlling the spread of the disease harder.

The Justice Department is taking aim at pricey “skin substitutes,” an overused wound care treatment that cost the government $10 billion in 2024.

Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be widely available — for free — to doctors.

Activists said more action was needed to solve the larger problem: Only 12 percent of Pakistani women and girls use safe, commercially made menstrual products.

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.

The White House recently endorsed monitoring sewage for evidence of drug use. Critics fear such efforts could violate privacy and stigmatize neighborhoods.

The U.V. Okies have dominated a competition with other senior living facilities for six seasons, but they’re not just there to win.

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

It’s hot in North America in June, but fans are griping that the breaks that have been added to each half are an excuse for the networks to show more ads.

The State Department is taking over much of the control of global health initiatives, for which critics say the department does not have the expertise.

The oldest known cases, discovered among hunter-gatherers in Siberian graves, contradict the theory that the disease once was mild.

Five stories show the hurdles that people with psychological diagnoses face when considering parenthood.

As tech giants rush to build big data centers, some residents who live near them say a constant low-frequency vibration is ruining their health and homes.

Others who were in the facility have been allowed to return to their homes in recent weeks for monitoring by local health officials.

With support from Markwayne Mullin and Robert F. Kennedy Jr., the kratom industry is pursuing a potentially lucrative policy. Mr. Mullin owns equity in a company that could benefit.